John R. Burk

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

EEG feature extraction for classification of sleep stages

Edson Estrada, H. Nazeran, Patricia Nava et al. · 2005 · 79 citations

Sleep Disorders, Eeg Recordings, Engineering +19

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Zelalem Temesgen, Charles D. Burger, Jason Baker et al. · The Lancet Respiratory Medicine · 2021 · 70 citations · Full text

Covid-19 Pandemic, Respiratory Infection, Infectious Respiratory Disease +6

Periods of intermittent hypoxic apnea can alter chemoreflex control of sympathetic nerve activity in humans

Michael J. Cutler, Nicolette Muenter Swift, David M. Keller et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2004 · 62 citations

Hypertension, Social Sciences, Sleep-related Breathing Disorder +18

A noninvasive technique for detecting obstructive and central sleep apnea

Fu-Chung Yen, Khosrow Behbehani, E.A. Lucas et al. · IEEE Transactions on Biomedical Engineering · 1997 · 55 citations